carboplatin, gemcitabine , pametrexed

Developed for: lung cancer
Investigated by: Guangzhou Medical University · The First Affiliated Hospital of Guangzhou Medical University

today NCT01781988 · Ph 2

2009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT01781988	Jun 2009 → Dec 2014	lung cancer, poisoning	Guangzhou Medical University	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	carboplatin, gemcitabine , pametrexed	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01781988 ↗